During the past decade, Phoenix Cardiovascular Research Group conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 9 clinical trials were completed, i.e. on average, 47.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 9 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Phoenix Cardiovascular Research Group" #1 sponsor was "Abbott Medical Devices" with 9 trials, followed by "Boston Scientific Corporation" with 4 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 3 trials sponsored, "Biosense Webster, Inc." with 2 trials sponsored and "Ancora Heart, Inc." with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Phoenix Cardiovascular Research Group" #1 collaborator was "Abbott" with 1 trials as a collaborator and "Syntactx" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Phoenix Cardiovascular Research Group" are "Heart Failure" (8 trials), "Atrial Fibrillation" (6 trials), "Anemia" (1 trials), "Bleeding" (1 trials) and "Bleeding Disorder" (1 trials). Many other conditions were trialed in "Phoenix Cardiovascular Research Group" in a lesser frequency.

Most popular intervention types in "Phoenix Cardiovascular Research Group" are "Device" (21 trials) and "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "MPP" (2 trials), "AccuCinch Ventricular Restoration System" (1 trials), "Attain Stability Quad Left Ventricular Pacing Lead" (1 trials), "BAROSTIM NEO® System" (1 trials) and "BiV/MPP" (1 trials). Other intervention names were less common.

The vast majority of trials in "Phoenix Cardiovascular Research Group" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Phoenix Cardiovascular Research Group". undefined are not yet recruiting, 2 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Phoenix Cardiovascular Research Group, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Phoenix Cardiovascular Research Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 15 trials that are defined as “Not Applicable".